Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Upregulation of Type III endothelial cell Nitric Oxide Synthase by HMG-CoA reductase inhibitors

Upregulation of Type III endothelial cell Nitric Oxide Synthase by HMG-CoA reductase inhibitors

US Patent 6147109 · Granted Nov 14, 2000

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-inflammatory actions of cytochrome P450 expoxygenase-derived eicosanoids2005
Increasing cerebral bioavailability of drugs2004
Increasing cerebral bioavailability of drugs2004
Upregulation of type III endothelial cell nitric oxide synthase by agents that d2004
Endothelial NOS transgenic animals and methods of use2003
Methods of identifying a compound which modulates the non-transcriptional non-ma2003
Liquid crystal display2003
Liquid crystal display2003
Upregulation of type III endothelial cell nitric oxide synthase by agents that d2002
Use of MEK1 inhibitors as protective agents against damage due to ischemia2001
Endothelial NOS knockout mice and methods of use2001
Upregulation of Type III endothelial cell nitric oxide synthase by rho GTPase fu2001